Paperpal Prime Logo

Blood Science : Impact Factor & More

eISSN: 2543-6368pISSN: 2543-6368
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Blood Science

Blood Science Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher LIPPINCOTT WILLIAMS & WILKINS
Language English
Frequency Quarterly
Publication Time10
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorChinese Association for Blood Sciences
FrequencyQuarterly
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 10
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Blood Science ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Blood Science

Application value and challenges associated with plasma cell-free DNA metagenomic sequencing technology in the diagnosis of infections in patients with hematological disorders.
  • 1 Sep 2026
  • Blood science (Baltimore, Md.)
Refining favorable-risk classification in pediatric RUNX1::RUNX1T1 acute myeloid leukemia.
  • 1 Sep 2026
  • Blood science (Baltimore, Md.)
Patient-centered and coordinated therapy with RNA interference-based givosiran for acute hepatic porphyria: real-life experience for an ultra-rare disease from Romania
  • 31 Jul 2026
  • Blood Science
STAT3 inhibition eradicates multiple myeloma stem-like cells and induces immunogenic cell death
  • 31 Jul 2026
  • Blood Science
Febrile neutropenia adversely affects chemomobilization outcomes in patients with multiple myeloma and increases risk for post-transplant infection in those with lymphoma: real-world multicenter data
  • 19 Jun 2026
  • Blood Science
Transcriptomics-based multi-omics approach for optimizing risk stratification in acute myeloid leukemia
  • 17 Jun 2026
  • Blood Science
Application value and challenges associated with plasma cell-free DNA metagenomic sequencing technology in the diagnosis of infections in patients with hematological disorders.
  • 1 Sep 2026
  • Blood science (Baltimore, Md.)
Refining favorable-risk classification in pediatric RUNX1::RUNX1T1 acute myeloid leukemia.
  • 1 Sep 2026
  • Blood science (Baltimore, Md.)
Patient-centered and coordinated therapy with RNA interference-based givosiran for acute hepatic porphyria: real-life experience for an ultra-rare disease from Romania
  • 31 Jul 2026
  • Blood Science
STAT3 inhibition eradicates multiple myeloma stem-like cells and induces immunogenic cell death
  • 31 Jul 2026
  • Blood Science
Febrile neutropenia adversely affects chemomobilization outcomes in patients with multiple myeloma and increases risk for post-transplant infection in those with lymphoma: real-world multicenter data
  • 19 Jun 2026
  • Blood Science
Transcriptomics-based multi-omics approach for optimizing risk stratification in acute myeloid leukemia
  • 17 Jun 2026
  • Blood Science

FAQs on Blood Science